Home • Scientific literature watch • An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections
[acf:scientific_post_journal] • [acf:scientific_post_date]